Discover · casrai.org

No picture published by casrai.org

Novartis announces FDA approval of Cosentyx for polymyalgia rheumatica

casrai.org datasets casrai.org

This is what was read here when it was published. casrai.org no longer carries it in what it publishes now.

Novartis announced FDA approval of Cosentyx for polymyalgia rheumatica, linking REPLENISH trial evidence to a new US indication.

More ways to use this
Open on another device
Scan this QR code to open the same public page

Scan to open this page. Your saved notes and account access are not included.

Download QR code

Open the page link

Keep going

Each of these is read from what this estate already kept: the feed a piece came through, the publisher behind it, the credits and topics the publisher printed. None of it is a recommendation, an identity or a record kept anywhere else.

Also from casrai.org datasets

  1. [Dictionary] B-score (Statistical Metric)casrai.org
  2. [Dictionary] Nanomaterials Impact Factorcasrai.org
  3. MHRA Launches AdvanceGxP Service for Medicines Manufacturingcasrai.org
  4. EU Sanctions Office Established and Envoy Appointedcasrai.org
  5. EU plans five Innovation Fund calls worth up to €5.2 billion for 3 December 2026Listed at €5.2 casrai.org
  6. FDA issues draft guidance on early-phase IND trials for solid tumorscasrai.org